Jane Chung
Präsident bei SUTRO BIOPHARMA, INC.
Vermögen: 144 327 $ am 30.04.2024
Aktive Positionen von Jane Chung
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SUTRO BIOPHARMA, INC. | Geschäftsführer | 01.12.2023 | - |
| Präsident | 01.12.2023 | - | |
| Corporate Officer/Principal | 09.08.2021 | 01.12.2023 | |
| VIRACTA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 10.08.2022 | - |
| Independent Dir/Board Member | 10.08.2022 | - |
Karriereverlauf von Jane Chung
Ehemalige bekannte Positionen von Jane Chung
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Präsident | 01.11.2019 | 01.08.2021 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01.01.2013 | 01.01.2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Vertrieb & Marketing | 01.01.2003 | 01.01.2013 |
Ausbildung von Jane Chung
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| St. John's University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| President | 2 |
| Undergraduate Degree | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| VIRACTA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology AstraZeneca Canada, Inc. develops and manufactures pharmaceutical drug preparations. Its therapeutic areas include cardiovascular and metabolic disease, oncology, and respiratory, inflammation and autoimmunity. The firm also active in the infection, neuroscience and gastrointestinal disease areas. The company was founded in 1999 and is headquartered in Mississauga, Canada. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Jane Chung
- Erfahrung